MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy
Cornel, A.M.; Mimpen, I.L.; Nierkens, S. MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy. Cancers 2020, 12, 1760. https://doi.org/10.3390/cancers12071760
Cornel AM, Mimpen IL, Nierkens S. MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy. Cancers. 2020; 12(7):1760. https://doi.org/10.3390/cancers12071760
Chicago/Turabian StyleCornel, Annelisa M., Iris L. Mimpen, and Stefan Nierkens. 2020. "MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy" Cancers 12, no. 7: 1760. https://doi.org/10.3390/cancers12071760